Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by langostaon Sep 18, 2018 1:45pm

106 Views

Post# 28640514

Customary Closing Conditions.

Subject to satisfaction of certain customary closing conditions, the offering is expected to close in one or more tranches on or before September 14, 2018. T
Provision of closing certificates that state representations and warranties have been satisfied by both parties
Provision that each party's representations and warranties are valid as of the closing and/or signing date
Approval by governmental authority for the transaction to take place, if applicable
Provision of fully executed ancillary documents by both parties
Condition by the seller that the buyer has met the purchase price
Deal specific conditions by the buyer that specific issues are addressed, such as pending liabilities
Joint condition that no pending litigation would prevent the deal from closing
Buyer condition that the seller obtains consent from third parties, such as suppliers
Joint condition that the transaction is legal by law